What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

***OFFICIAL CYDY/Leronlimab Thread*** (3 Viewers)

I hate to agree with him but definitely weird timing and this is just an odd quote with the trial about to report:

CytoDyn CEO Nader Pourhassan has said: "We believe [Vyrologix] will be an important part of many therapeutics including HIV, cancer and now NASH. We also hope to play a critical role in reducing mortality in patients infected with COVID-19.

I’ve got no skin in the game anymore but was in it so long I still keep tabs on the thread. Just really odd to be setting the table on other areas at this time.

 
Proactive Investors is pay-for-play.  You're more likely to get a freebie from a prostitute than Proactive.
Yeah for the most part it is, do they cover off on their own editorial on companies that pay them though, possibly.  I think this is the latter. 
I really don't think NP instructed them to write that and if he did it sounds a month or so old.

 
Yeah for the most part it is, do they cover off on their own editorial on companies that pay them though, possibly.  I think this is the latter. 
I really don't think NP instructed them to write that and if he did it sounds a month or so old.
Proactive has a contract with CytoDyn.  Do you really think they're going to freelance an article without authorization from Nader?

 
Proactive has a contract with CytoDyn.  Do you really think they're going to freelance an article without authorization from Nader?
I guess we can just disagree, I don't see anything meaningful in that article.  I highly doubt this is how he plans to signal that the trial is a failure by some incomplete message in a Proactive article but if you want to read that much into it, go for it.
 

 
Dwayne Hoover said:
I guess we can just disagree, I don't see anything meaningful in that article.  I highly doubt this is how he plans to signal that the trial is a failure by some incomplete message in a Proactive article but if you want to read that much into it, go for it.
 
But we have to admit, another bad optic. What a mess, they just can't get out of their own way. Disappointing.

 
It's not a strong enough signal either way to make anything out of it. Could just be filler to keep people guessing until they have results. I can't make any case either way for it.

 
I'm more worried that Nader cannot write a simple PR clearly and we expect the FDA will want to work with them on things that are far more complicated.  That's the red flag if you are looking for one.

 
Yah I read it and didn't seem like a clear negative or positive. It's just a summary of where we're at. COVID trails were mentioned first and throughout. 

Assuming NP did ok this the "results in early 2021" is a slight worry. That NP speak for basically February or March...meaning top line results weren't great.

 
I just re-read it and I don't like it.  Anytime he writes something to remind us of the other indications, it isn't a positive for Covid. If any similar news release comes out from the company news site, I will definitely pull back a little.  

 
I emailed the author to ask him about the article.  This is what he told me and honestly I LOL at his description of "deep dive"

"That article is what we call a Deep Dive, a broad article that stays on a company's profile page and receives periodic updates. For CytoDyn, we of course wanted to discuss their work with the coronavirus, but more importantly provide a general overview of all the indications the company is pursuing for leronlimab (now known by its brand name Vyrologix). "

 
Nick Agresti  Gastroenterologist                          4h

Thank you for all of your kind words. Clinical trial results will be out very soon.
From LinkedIn Link

 
Last edited by a moderator:
Agresti has been aggressively promoting leronlimab since his paper came out.  

@Don Hutsonyou remarked a few weeks ago that there weren't any new doctors in the mix. Agresti is one that is absolutely on board with leronlimab.
Agresti is not a world class virologist.  He is not even a virologist.  He is a gastroenterologist who practices in Brunswick, Georgia.  He earned his medical degree from American University of the Caribbean School of Medicine in St. Maarten, Netherlands Antilles.  Word on the street is that he did stay at a Holiday Inn Express last night so he has that going for him.

 
My Facebook feed has started to get inundated with monoclonal antibody advertising.  Facebook, you know me so well.
A nurse friend of mine just posted an article over the weekend about this fantastic Covid treatment called monoclonal antibodies.  She said her hospital (large hospital system in Detroit area) is giving infusions of Bamlanivimab which sounds like is approved for EUA.  However, Bamlanivimab has to be given within 10 days of onset of symptoms.

 
A nurse friend of mine just posted an article over the weekend about this fantastic Covid treatment called monoclonal antibodies.  She said her hospital (large hospital system in Detroit area) is giving infusions of Bamlanivimab which sounds like is approved for EUA.  However, Bamlanivimab has to be given within 10 days of onset of symptoms.
That's Lilly's mab.  It was given an EUA.  Like you said, it is given early.  So it really doesn't compete with leronlimab.

 
Last edited by a moderator:
I like HGEN's primary endpoint more.  Instead of death at 28 days it is ventilator-free survival at day 28.  How many placebo patients were living out their last days on a ventilator at day 28 in the CYDY trial?  Makes more sense.

 
I like HGEN's primary endpoint more.  Instead of death at 28 days it is ventilator-free survival at day 28.  How many placebo patients were living out their last days on a ventilator at day 28 in the CYDY trial?  Makes more sense.
There are arguments for it but they have now switched their endpoint in the phase 3 a couple of times now.   It's not ideal that they weren't able to design their trial around a settled endpoint.  

I bailed on HGEN today, made some scratch and very well may leave money on the table but I'm good with where I'm at on it.  

 
I like HGEN's primary endpoint more.  Instead of death at 28 days it is ventilator-free survival at day 28.  How many placebo patients were living out their last days on a ventilator at day 28 in the CYDY trial?  Makes more sense.
I actually bought more today. I think it will get some approval, seems like they are trying to help them here, not hurt them. 

 
You guys are in luck if you need anal surgery after CYDY's impending stock price crash rips you a new ahole because Brunswick, Georgia's finest gastroenterologist, Dr Nicholas Agresti, performs just such a procedure.  Maybe Dwayne could email his penpal Dr Nick and ask for a group discount.

https://www.healthgrades.com/physician/dr-nicholas-agresti-yn7n4

Dr. Nicholas Agresti, MD is a Gastroenterology Specialist in Brunswick, GA. Dr. Agresti has more experience with Esophageal Disorders, Anal & Rectal Surgery, and Gastrointestinal Disorders than other specialists in his area. He is affiliated with medical facilities Southeast Georgia Health System - Brunswick and Southeast Georgia Health System - Camden. He is accepting new patients and has indicated that he accepts telehealth appointments. Be sure to call ahead with Dr. Agresti to book an appointment.
Oh wait, prolly better not to get anal surgery in a moldy operating room

https://www.healthgrades.com/physician/dr-nicholas-agresti-yn7n4

I went to Dr Agresti due to needing an endoscopy for Barrett s and a colonoscopy. The office was filthy and had mold throughout, blackouts occurred while waiting for him and they were doing surgery. He flat out lied and told me my insurance would not cover an endoscopy and colonoscopy at same time, said I had to have them done separately in same week. The scheduler was the rudest woman I have ever met yelling at me because I did not want to get a covid test on Christmas Eve. The place should be shut down by the board of health. I despise lying doctors who WA t to profit especially during covid making patients endure general anesthesia twice. Going to Jacksonville. The hospital should be ashamed.
Rectum?  Damn near killed him!

 
Last edited by a moderator:
The stock price is holding strong at $5.00.  It could even be a good entry point for a day trade.  Although, it would only take one whale like Chet with cold feet to send the stock tumbling.

 
The trial is said to have ended 7 days ago.  If the data was good, we'd likely have heard the topline results.
Possibly.  They do have to wait for each hospital to sign off on everything before all the data is sent back.  I would expect that once the trial ends it could take up to a week to retrieve all the information from each hospital.

I'm giving them until the weekend before I start thinking about reducing my risk.  

 
Patterson decided to air some dirty laundry about Cytodyn today.  The soap opera is always on in the background with this company.  

https://twitter.com/brucep13/status/1351940986897719302

Shortly after, he still shows that he is behind leronlimab

https://twitter.com/brucep13/status/1351959732647411713
He is behind the drug, but not behind management.  The company is horribly run.  There is a legitimate dislike for NP in the BP world.  Not just because companies are envious of LL, but because NP is greasy

 
The company is horribly run.  There is a legitimate dislike for NP in the BP world.  Not just because companies are envious of LL, but because NP is greasy
Yes, I think we all agree on this, yet stay invested.

I do hope that this trial exceeds expectations because everything you mentioned above does not give me any confidence the FDA will want to work with them if they don't quite get there but are close.

 
I think I will sell 5% a day.  The longer this drags out, the worse the results will be.
I'm subscribed to this model, although my percentage is going up starting tomorrow.

Made some bank on this thing already and don't intend to cut into it too much.   If NP delivers and I leave money on the table, I'll still be happy.

 
Bid 5.11 x 100

Ask 5.18 x 100

This stock has about as much interest as this thread right now.

 

Users who are viewing this thread

Back
Top